S1PR2 antagonist alleviates oxidative stress-enhanced brain endothelial permeability by attenuating p38 and Erk1/2-dependent cPLA2 phosphorylation

Changchun Cao(Nanjing Medical University), Shengnan Li(Zhengzhou Normal University), Junyu Mu(Nanjing Medical University), Yali Hong(Nanjing Medical University), Li Dai(Nanjing Medical University), Xiaofei Wang(Louisiana State University Health Sciences Center New Orleans), Chao Zhu(Shandong Provincial Hospital), Lai Jin(Nanjing Medical University)
Cellular Signalling
October 2, 2018
10.1016/j.cellsig.2018.09.019
Cited by 51

Related Papers

Link between triglyceride-glucose-body mass index and future stroke risk in middle-aged and elderly chinese: a nationwide prospective cohort study
|Cardiovascular Diabetology|2024|104
<i>Mycoplasma genitalium</i>Infections in Asymptomatic Men and Men with Urethritis Attending a Sexually Transmitted Diseases Clinic in New Orleans
|Clinical Infectious Diseases|2002|98
Nonlinear relationship between atherogenic index of plasma and the risk of prediabetes: a retrospective study based on Chinese adults
|Cardiovascular Diabetology|2023|85
Retracted: Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target
|Journal of Medical Genetics|2018|75
Activating AhR alleviates cognitive deficits of Alzheimer's disease model mice by upregulating endogenous Aβ catabolic enzyme Neprilysin
|Theranostics|2021|73